News from Zentiva


May 13, 2024    /    2024

Zentiva joins as first industry partner

Prague, May 13, 2024 – is a professional group whose main goals include the development of the biotechnology segment in the Czech Republic and increase its visibility internationally. Until now, it has brought together institutions that represent highly professional research centers with a strong influence on the development of new drugs, diagnostic methods and other medical technologies. Now Zentiva, has entered the biotechnology cluster as the first representative of the industry.

The biotechnological cluster was founded in the fall of last year and has so far consisted of six institutions from the academic environment: Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic, biotechnology incubator i&i Prague, Biotechnology Institute of the Academy of Sciences of the Czech Republic, Institute of Microbiology of the Academy of Sciences of the Czech Republic, Institute of Molecular Genetics of the Academy of Sciences of the Czech Republic Czech Republic and the University of Chemistry and Technology in Prague.

"The accession of Zentiva is a turning point for, as it is an important step towards fulfilling the basic mission of the association. This is the linking of science, industry and business. At the same time, we are very happy that the first non-academic representative in our association is Zentiva, a successful international company with its roots in the Czech Republic, which, in addition to production, also has a global research and development center here, and is among the top 10 investors in research and development in the Czech Republic," says Petra Kinzlová, CEO of the association.

Sharing and cooperation for the development of innovation potential
Zentiva's accession to the association follows on from cooperation during the first year of the aforementioned conference, in which Zentiva representatives actively participated. "The pharmaceutical industry has a long tradition in the Czech Republic. At Zentiva, we care that it stays here, grows and brings innovation and access to affordable treatment to those who need it. For a long time, we have participated in the development of Czech pharmaceutical science through the education of experts for industry and close cooperation with universities, for example within the Center for Applied Research, The PARC. Joining is the next logical step for us in building the domestic pharmaceutical potential, and we are pleased to have found another partner who shares the same vision," says Martin Albert, Chief Scientific Officer at Zentiva.
About Zentiva
Zentiva is a pan-European platform that develops, manufactures and delivers high-quality, affordable medicines to more than 100 million people in Europe. Zentiva has 4 wholly owned manufacturing plants and a wide network of external manufacturing partners. It offers solutions in key therapeutic areas such as cardiology and circulatory diseases, diabetes, oncology, respiratory diseases and neurology, and is focused on expanding its portfolio in the field of Consumer Healthcare Products. The company is owned by an investment fund and delivers sustainable double-digit growth with an ambitious five-year plan for further strong growth across Europe.
Zentiva consists of a team of 5,000 unique talents bonded together by delivering high-quality, affordable medicines to the people who depend on them every day. Zentiva is a great place to work where everyone feels welcome and valued, and where they can be their true selves and contribute to their best ability. We deliver on our purpose to provide health and wellbeing to all generations. 
The association was founded in the autumn of last year. It is a platform that aims to connect innovators, academic institutions, industry representatives, investors and other important actors in the field of biotechnology. The association is the organizer of the conference, the second year of which will take place on September 24 in the Slovanský dům in Prague. It also represents its members at important international conferences, most recently at Bio-Europe Spring, which took place this year in Barcelona, Spain.

Media Contact:
Ines Windisch, 
Head of Communications, Corporate Affairs & Sustainability